Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

by Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta Jnr D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N
Published 2021-02-01

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series

by Menzella F, Bonavia M, Bonini M, D'Amato M, Lombardo S, Murgia N, Patella V, Triggiani M, Pelaia G
Published 2021-02-01

Update on optimal use of omalizumab in management of asthma

by Pelaia G, Gallelli L, Renda T, Romeo P, Busceti MT, Grembiale RD, Maselli R, Marsico SA, Vatrella A
Published 2011-06-01

Dupilumab: a novel treatment for asthma

by Vatrella A, Fabozzi I, Calabrese C, Maselli R, Pelaia G
Published 2014-09-01

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis

by Pelaia C, Lombardo N, Busceti MT, Piazzetta G, Crimi C, Calabrese C, Vatrella A, Pelaia G
Published 2021-09-01